344 POSTER A phase Ib dose escalation study to evaluate safety and tolerability of the combination of the aminopeptidase inhibitor CHR-2797 and paclitaxel in patients with advanced or treatment refractory tumors
C. van Herpen, F. Eskens, M. de Jonge, I. Desar, L. Hooftman, E. Bone, A. Timmer-Bonte, J. VerweijVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72278-x
File:
PDF, 59 KB
english, 2008